Soleus Capital Management’s Veracyte VCYT Stock Holding History

Soleus Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.3M	Buy	319,912 +309,912	+3,099%	+$11.5M	0.42%	47
2025 Q4	$421K	Sell	10,000 -412,055	-98%	-$16.6M	0.02%	88
2025 Q3	$14.5M	Sell	422,055 -293,384	-41%	-$8.42M	0.73%	35
2025 Q2	$19.3M	Buy	+715,439	New	+$20.7M	1.28%	26
2024 Q4	–	Sell	-54,303	Closed	-$1.85M	–	109
2024 Q3	$1.85M	Buy	+54,303	New	+$1.53M	0.14%	80

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Soleus Capital Management's VCYT Position: Q1 2026 in Review

Soleus Capital Management increased its Veracyte (VCYT) stake by 3,099% in Q1 2026, buying an estimated $11.5M and bringing the position to 319,912 shares worth $10.3M. The position accounts for 0.42% of the portfolio, ranked #47.

Soleus Capital Management first reported a position in VCYT in Q3 2024 and has held it in 5 quarters since. The position peaked at $19.3M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Soleus Capital Management held 319,912 shares of Veracyte worth $10.3M as of Q1 2026.
Soleus Capital Management bought 309,912 Veracyte shares in Q1 2026, an estimated $11.5M.
Veracyte made up 0.42% of Soleus Capital Management's portfolio in Q1 2026, its #47 holding.
Soleus Capital Management first reported a position in Veracyte in Q3 2024 and has held it in 5 quarters since.
Soleus Capital Management's Veracyte position peaked at $19.3M in Q2 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.